RS
Ritesh Srivastava
About Ritesh Srivastava
Data last updated:
Ritesh Srivastava is a Director at Nexgenrx Pharmaceuticals Private Limited (since 2019). The companies operate in Pharma, Fashion and Textile and Food and Beverages. Nexgenrx Pharmaceuticals Private Limited reported revenue of ₹14.89 Cr (FY 2024). Earlier, Ritesh Srivastava was a Director at Ardee Komfab Private Limited (2007–2010) and Director at Pashlo Exim India Private Limited (2007–2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nexgenrx Pharmaceuticals Private Limited U36994DL2016PTC302167 | Director | 07 Jan 2019 | 2016 | ₹14.89 Cr (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ardee Komfab Private Limited U17120HR2007PTC037387 | Director | 15 Nov 2007 | 2007 | ₹3.59 Cr (FY 2024) | Active |
| Pashlo Exim India Private Limited U74110DL2007PTC162014 | Director | 13 Apr 2007 | 2007 | ₹8,000 (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ritesh Srivastava
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mohammad Rashid Hasan | 02290185 | Nexgenrx Pharmaceuticals Private Limited | Director |
| Pankaj Kumar Shrivastwa | 08507211 | Nexgenrx Pharmaceuticals Private Limited | Additional Director |
| Ram Mohan Jha | 08507215 | Nexgenrx Pharmaceuticals Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ritesh Srivastava
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ritesh Srivastava
Ritesh Srivastava currently holds 1 directorship: Nexgenrx Pharmaceuticals Private Limited (Director, since 07 Jan 2019, revenue ₹14.89 Cr (FY 2024)).
Ritesh Srivastava was first appointed on 13 Apr 2007 as Director at Pashlo Exim India Private Limited. The most recent appointment on record is 07 Jan 2019 at Nexgenrx Pharmaceuticals Private Limited.
Ritesh Srivastava held 2 earlier board appointments: Ardee Komfab Private Limited (Director, 15 Nov 2007 to 19 Jul 2010); Pashlo Exim India Private Limited (Director, 13 Apr 2007 to 10 Feb 2020).
The current boards of Ritesh Srivastava's companies include Mohammad Rashid Hasan (Nexgenrx Pharmaceuticals Private Limited), Pankaj Kumar Shrivastwa (Nexgenrx Pharmaceuticals Private Limited), Ram Mohan Jha (Nexgenrx Pharmaceuticals Private Limited).